NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its third quarter 2025 financial results before the
Oscar Health stock price has been in a strong uptrend in the past few weeks as the company shared plans on integrating artificial intelligence (AI) into its business. OSCR surged to a high of $24.2, i
Oscar Health, an ACA marketplace pure play, is leading the way.
Oscar Health, Inc. (OSCR) reached $19.28 at the closing of the latest trading day, reflecting a +2.01% change compared to its last close.
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $18.93, marking a -1.05% move from the previous day.

10 Hidden-Gem AI Stocks to Buy Right Now

06:45am, Saturday, 27'th Sep 2025
While Nvidia and Microsoft dominate artificial intelligence (AI) headlines, the smartest opportunities might lurk in smaller companies solving specific problems with the tech. These 10 hidden gems don

Oscar Health: Buy Now On ACA Concerns

10:49am, Thursday, 25'th Sep 2025
Oscar Health (OSCR) remains up 31% YTD as investors watch for developments on ACA enhanced subsidies, a key driver for its marketplace business. Policy risk looms with potential ACA subsidy expiration
MIAMI, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs, a leader in thematic and leveraged exchange-traded funds, today announced the launch of the Defiance Daily Target 2X Long OSCR ETF (Ticker: OSC
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $18.5, marking a -2.48% move from the previous day.
Oscar Health Inc OSCR just became one of Wall Street's buzziest policy trades. With ACA (Affordable Care Act) subsidy chatter swirling ahead of a possible government shutdown, the tech-driven insurer
Oscar Health is a volatile stock with high option premiums. A cash-secured put is one way to buy the stock for a discount.
Oscar Health stock is up 21% since my strong buy rating, outperforming the S&P 500's 4% return. Membership surpassed 2.0 million in June 2025, growing 28% year-over-year compared to just 13% ACA marke
Healthcare tech firm Oscar Health Inc. OSCR priced its offering of $355 million of 2.25% convertible senior subordinated notes due 2030 in a private offering.
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR) today announced the pricing of its offering of $355,000,000 aggregate principal amount of 2.25% convertible senior subordinated
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $18.73, marking a -3.1% move from the previous day.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE